• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫突触-神经突状态失衡反映胶质母细胞瘤对免疫的逃逸。

Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.

机构信息

Department of Biochemistry and Molecular Biology, School of Medicine, and.

Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Barcelona, Spain.

出版信息

JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.120757.

DOI:10.1172/jci.insight.120757
PMID:30232280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237222/
Abstract

Since the proper activation of T cells requires the physical interaction with target cells through the formation of immunological synapses (IS), an alteration at this level could be a reason why tumors escape the immune response. As part of their life cycle, it is thought that T cells alternate between a static phase, the IS, and a dynamic phase, the immunological kinapse (IK), depending on high or low antigen sensing. Our investigation performed in tissue samples of human glioma shows that T cells are able to establish synapsing interactions not only with glioma tumorigenic cells, but also with stromal myeloid cells. Particularly, the IS displaying a T cell receptor-rich (TCR-rich) central supramolecular activation cluster (cSMAC) is preferentially established with stromal cells, as opposed to malignant cells. Conversely, T cells in the malignant areas showed distinct morphometric parameters compared with nonneoplastic tissue - the former characterized by an elongated shape, well-suited to kinaptic dynamics. Importantly, high-resolution 3-dimensional analyses demonstrated the existence of bona-fide IK preferentially arranged in malignant areas of the tumor. This imbalance of IS/IK states between these 2 microenvironments reveals the low antigenic sensing of T cells when patrolling tumorigenic cells and reflects the immunoevasive environment of the tumor.

摘要

由于 T 细胞的适当激活需要通过形成免疫突触(IS)与靶细胞进行物理相互作用,因此这种水平的改变可能是肿瘤逃避免疫反应的原因之一。在它们的生命周期中,人们认为 T 细胞在静态阶段(IS)和动态阶段(IK)之间交替,这取决于高或低的抗原感应。我们在人类神经胶质瘤组织样本中的研究表明,T 细胞不仅能够与神经胶质瘤肿瘤细胞建立突触相互作用,还能够与基质髓样细胞建立突触相互作用。特别是,具有 T 细胞受体丰富(TCR-rich)中央超分子激活簇(cSMAC)的 IS 优先与基质细胞而不是恶性细胞建立。相反,与非肿瘤组织相比,恶性区域的 T 细胞表现出不同的形态计量参数——前者的特点是形状细长,非常适合动力学。重要的是,高分辨率 3 维分析表明,在肿瘤的恶性区域存在真正的 IK 优先排列。这两种微环境之间的 IS/IK 状态的不平衡揭示了 T 细胞在巡逻肿瘤细胞时对低抗原的感应,并反映了肿瘤的免疫逃避环境。

相似文献

1
Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.免疫突触-神经突状态失衡反映胶质母细胞瘤对免疫的逃逸。
JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.120757.
2
Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells.人类胶质母细胞瘤中浸润的细胞毒性T淋巴细胞(CTL)与致瘤细胞形成免疫突触。
Am J Pathol. 2009 Aug;175(2):786-98. doi: 10.2353/ajpath.2009.081034. Epub 2009 Jul 23.
3
Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo.库普弗型免疫突触特征不能预测体内抗脑肿瘤细胞毒性 T 细胞的功能。
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4716-21. doi: 10.1073/pnas.0911587107. Epub 2010 Jan 19.
4
Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.毛细胞型星形细胞瘤和胶质母细胞瘤的免疫细胞浸润差异:反映肿瘤生物学的不同免疫微环境的证据。
J Neurosurg. 2011 Sep;115(3):505-11. doi: 10.3171/2011.4.JNS101172. Epub 2011 Jun 10.
5
Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.免疫突触处可溶性和膜结合分子对肿瘤免疫的调节作用。
Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7.
6
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.在神经胶质瘤微环境中,髓系细胞释放白细胞介素 10 介导 T 细胞功能障碍。
Nat Commun. 2022 Feb 17;13(1):925. doi: 10.1038/s41467-022-28523-1.
7
Harnessing the immune system in glioblastoma.利用免疫系统治疗胶质母细胞瘤。
Br J Cancer. 2018 Nov;119(10):1171-1181. doi: 10.1038/s41416-018-0258-8. Epub 2018 Nov 5.
8
The Dynamics of Interactions Among Immune and Glioblastoma Cells.免疫细胞与胶质母细胞瘤细胞之间相互作用的动力学
Neuromolecular Med. 2015 Dec;17(4):335-52. doi: 10.1007/s12017-015-8362-x. Epub 2015 Jul 30.
9
Targeting EGFRvIII for glioblastoma multiforme.针对多形性胶质母细胞瘤的表皮生长因子受体III型变异体(EGFRvIII)
Cancer Lett. 2017 Sep 10;403:224-230. doi: 10.1016/j.canlet.2017.06.024. Epub 2017 Jun 23.
10
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.胶质瘤中的癌症干细胞和免疫抑制微环境。
Front Immunol. 2018 Dec 21;9:2924. doi: 10.3389/fimmu.2018.02924. eCollection 2018.

引用本文的文献

1
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency.溶液结构和突触分析揭示了双特异性T细胞衔接器效力的决定因素。
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2425781122. doi: 10.1073/pnas.2425781122. Epub 2025 May 30.
2
MARC, a novel modular chimeric antigen receptor, improves T cell-based cancer immunotherapies by preventing early T cell exhaustion and enhancing persistence.MARC是一种新型的模块化嵌合抗原受体,它通过防止早期T细胞耗竭和增强持久性来改善基于T细胞的癌症免疫疗法。
J Immunother Cancer. 2025 Apr 20;13(4):e011829. doi: 10.1136/jitc-2025-011829.
3
The Three Pillars of Glioblastoma: A Systematic Review and Novel Analysis of Multi-Omics and Clinical Data.胶质母细胞瘤的三支柱:多组学和临床数据的系统评价及新分析。
Cells. 2024 Oct 23;13(21):1754. doi: 10.3390/cells13211754.
4
Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies.可解释机器学习在免疫突触剖析和治疗性抗体功能表征中的应用。
Nat Commun. 2023 Nov 30;14(1):7888. doi: 10.1038/s41467-023-43429-2.
5
Development of bispecific T cell engagers: harnessing quantitative systems pharmacology.双特异性 T 细胞衔接器的开发:利用定量系统药理学。
Trends Pharmacol Sci. 2023 Dec;44(12):880-890. doi: 10.1016/j.tips.2023.09.009. Epub 2023 Oct 17.
6
Innate immune response restarts adaptive immune response in tumors.先天免疫反应在肿瘤中重新启动适应性免疫反应。
Front Immunol. 2023 Sep 14;14:1260705. doi: 10.3389/fimmu.2023.1260705. eCollection 2023.
7
Classification of T lymphocyte motility behaviors using a machine learning approach.基于机器学习的 T 淋巴细胞运动行为分类。
PLoS Comput Biol. 2023 Sep 11;19(9):e1011449. doi: 10.1371/journal.pcbi.1011449. eCollection 2023 Sep.
8
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection.免疫突触揭示慢性 HIV 感染期间 CD8 T 细胞的异常功能。
Nat Commun. 2022 Oct 28;13(1):6436. doi: 10.1038/s41467-022-34157-0.
9
A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma.组织免疫成分的定量数字分析揭示了胶质母细胞瘤中具有相关预后意义的免疫抑制和无反应性免疫反应。
Biomedicines. 2022 Jul 21;10(7):1753. doi: 10.3390/biomedicines10071753.
10
Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma.定量系统药理学模型揭示了三特异性 T 细胞接合器在多发性骨髓瘤中的剂量反应关系。
Sci Rep. 2022 Jun 29;12(1):10976. doi: 10.1038/s41598-022-14726-5.

本文引用的文献

1
Current state of immunotherapy for glioblastoma.胶质母细胞瘤的免疫治疗现状。
Nat Rev Clin Oncol. 2018 Jul;15(7):422-442. doi: 10.1038/s41571-018-0003-5.
2
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.一线纳武利尤单抗用于IV期或复发性非小细胞肺癌
N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493.
3
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.免疫治疗后的超进展者:与加速生长率相关的基因组改变分析。
Clin Cancer Res. 2017 Aug 1;23(15):4242-4250. doi: 10.1158/1078-0432.CCR-16-3133. Epub 2017 Mar 28.
4
Studying the T Cell-Astrocyte Immune Synapse.研究T细胞-星形胶质细胞免疫突触。
Methods Mol Biol. 2017;1584:517-531. doi: 10.1007/978-1-4939-6881-7_32.
5
Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.肿瘤浸润淋巴细胞对抗原呈动态脱敏,但由稳态细胞因子维持。
JCI Insight. 2016 Dec 8;1(20):e89289. doi: 10.1172/jci.insight.89289.
6
PD-1 and Foxp3 T cell reduction correlates with survival of HCC patients after sorafenib therapy.PD-1和Foxp3 T细胞减少与索拉非尼治疗后肝癌患者的生存率相关。
JCI Insight. 2016 Jul 21;1(11). doi: 10.1172/jci.insight.86182.
7
The cytotoxic T lymphocyte immune synapse at a glance.细胞毒性T淋巴细胞免疫突触一览。
J Cell Sci. 2016 Aug 1;129(15):2881-6. doi: 10.1242/jcs.186205.
8
PD-1 marks dysfunctional regulatory T cells in malignant gliomas.程序性死亡受体1(PD-1)标记恶性胶质瘤中功能失调的调节性T细胞。
JCI Insight. 2016 Apr 21;1(5). doi: 10.1172/jci.insight.85935.
9
Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy.分子途径:打破嵌合抗原受体和T细胞受体基因疗法治疗上皮癌的障碍
Clin Cancer Res. 2016 Apr 1;22(7):1559-64. doi: 10.1158/1078-0432.CCR-15-1294.
10
CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors.CD4(+) T细胞失能可预防自身免疫并产生调节性T细胞前体。
Nat Immunol. 2016 Mar;17(3):304-14. doi: 10.1038/ni.3331. Epub 2016 Feb 1.